The expression of IL12Rβ2 was higher in the metastatic tumors in head and neck cancers as well as breast cancers, and the effect was more prominent in early breast cancers (Fig. 9p–r, Supplementary Figure 7j–k). This evidence concerns the gene IL12RB2 and breast cancer.